Susannah C. Cooper

Hematology

1315 S La Canada Dr
Green Valley, AZ 85622

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Novel Brentuximab Vedotin Combination Therapies Show Promising Activity in Highly Refractory CD30+ Non-Hodgkin Lymphoma: A Case Series and Review of the Literature.

Novel Brentuximab Vedotin Combination Therapies Show Promising Activity in Highly Refractory CD30+ Non-Hodgkin Lymphoma: A Case Series and Review of the Literature.

Journal: Case reports in oncological medicine

Published: April 13, 2016

Showing 1-1 of 1

Last Updated: 09/26/2026